Drugs for weight loss like liraglutide (Saxenda, Victoza) have been around for years, with newer arrivals like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) offering an even ...

Important aspects of prescribing orlistat are summarised in the NICE Clinical Knowledge Summary (CKS) obesity prescribing information. Liraglutide NICE recommends liraglutide as an option for weight ...

The proportion of patients who lost 10% or more of their body weight by 9 months was highest for liraglutide (31.3%), followed by lorcaserin (11.7%) and orlistat (6.0%).

Liraglutide injections appear to be safe for most people the drug is suitable for. A 2015 study — funded by Novo Nordisk — included more than 3,700 participants who didn’t have type 2 diabetes.

Liraglutide (Saxenda) 4.8%. ... orlistat, was not recommended because it led to small amounts of weight loss and the side effects meant many people stopped using it.

Drugs for weight loss like liraglutide (Saxenda, Victoza) have been around for years, with newer arrivals like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) offering an even ...

More than 80% of adults who are prescribed an obesity medication discontinue taking them at 1 year, though persistence rates are higher for adults receiving semaglutide and liraglutide, according ...

Liraglutide is generally only prescribed after a GP refers you to a specialist weight loss management service and when orlistat hasn't worked. Side effects include a ches and pains, diarrhoea ...